92
Views
16
CrossRef citations to date
0
Altmetric
Review

Potential role of a new PEGylated recombinant factor VIII for hemophilia A

&
Pages 121-128 | Published online: 20 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gianna M Guzzardo, Robert Sidonio, Jr, Michael U Callaghan & Katherine Regling. (2022) Early stage clinical trials for the treatment of hemophilia A. Expert Opinion on Investigational Drugs 31:11, pages 1169-1186.
Read now
Massimo Morfini. (2017) Simoctocog alfa for the treatment of hemophilia A. Expert Opinion on Biological Therapy 17:12, pages 1573-1580.
Read now

Articles from other publishers (13)

Tahereh Zadeh Mehrizi & Kamran Mousavi Hosseini. (2021) An overview on the investigation of nanomaterials' effect on plasma components: immunoglobulins and coagulation factor VIII, 2010–2020 review. Nanoscale Advances 3:13, pages 3730-3745.
Crossref
传荣 马. (2021) Advances in the Treatment of Hemophilia. Advances in Clinical Medicine 11:09, pages 4099-4104.
Crossref
Louis AledortScott MilliganMaureen WattJason Booth. (2020) A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United States. Journal of Managed Care & Specialty Pharmacy 26:4, pages 492-503.
Crossref
Mario Schiavoni, Mariasanta Napolitano, Gaetano Giuffrida, Antonella Coluccia, Sergio Siragusa, Valeria Calafiore, Giuseppe Lassandro & Paola Giordano. (2019) Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits. Frontiers in Medicine 6.
Crossref
PrakasKumar Mandal, Abhijit Phukan, Amrita Bhowmik, Debasis Gantait & Prantar Chakrabarti. (2019) Effect of tertiary prophylaxis with low-dose factor VIII in quality of life in adult patients with severe hemophilia A. Journal of Applied Hematology 10:3, pages 88.
Crossref
Ana Catarina Silva, Cládia Pina Costa, Hugo Almeida, João Nuno Moreira & José Manuel Sousa Lobo. 2020. Current Applications of Pharmaceutical Biotechnology. Current Applications of Pharmaceutical Biotechnology 115 153 .
Rahul Bhardwaj, Goutam Rath & Amit K. Goyal. (2018) Advancement in the treatment of haemophilia. International Journal of Biological Macromolecules 118, pages 289-295.
Crossref
Vijaya S. Pilli. 2018. Hematology - Latest Research and Clinical Advances. Hematology - Latest Research and Clinical Advances.
A. L. Dunn, S. P. Ahuja & E. S. Mullins. (2018) Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A. Haemophilia 24:3, pages e84-e92.
Crossref
Joseph S. Redman, J. Nicholas Francis, Robert Marquardt, Damon Papac, Alan L. Mueller, Debra M. Eckert, Brett D. Welch & Michael S. Kay. (2018) Pharmacokinetic and Chemical Synthesis Optimization of a Potent d -Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery . Molecular Pharmaceutics 15:3, pages 1169-1179.
Crossref
N. Shurko, T. Danysh & V. Novak. (2017) THE COAGULATION FACTOR VIII: STRUCTURE AND APPLICATION. Visnyk of Lviv University. Biological series:76, pages 184-192.
Crossref
Caiyun Yang, Changqian Cao, Yao Cai, Huangtao Xu, Tongwei Zhang & Yongxin Pan. (2017) Effects of PEGylation on biomimetic synthesis of magnetoferritin nanoparticles. Journal of Nanoparticle Research 19:3.
Crossref
Mamta Sethi & Pavan Gurha. (2017) Perioperative management of a patient with haemophilia-A for major abdominal surgery. Indian Journal of Anaesthesia 61:4, pages 354.
Crossref